323 related articles for article (PubMed ID: 32506523)
21. The histologic spectrum of soft tissue spindle cell tumors with NTRK3 gene rearrangements.
Suurmeijer AJ; Dickson BC; Swanson D; Zhang L; Sung YS; Huang HY; Fletcher CD; Antonescu CR
Genes Chromosomes Cancer; 2019 Nov; 58(11):739-746. PubMed ID: 31112350
[TBL] [Abstract][Full Text] [Related]
22. A low-grade malignant soft tissue tumor with S100 and CD34 co-expression showing novel CDC42SE2-BRAF fusion with distinct features.
Sheng SJ; Li JM; Zou YF; Peng XJ; Wang QY; Fang HS; Li X; Ding Y; Fan QH; Zhang ZH; Wei YZ; Gong QX
Genes Chromosomes Cancer; 2020 Oct; 59(10):595-600. PubMed ID: 32447786
[TBL] [Abstract][Full Text] [Related]
23. ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research.
Marchiò C; Scaltriti M; Ladanyi M; Iafrate AJ; Bibeau F; Dietel M; Hechtman JF; Troiani T; López-Rios F; Douillard JY; Andrè F; Reis-Filho JS
Ann Oncol; 2019 Sep; 30(9):1417-1427. PubMed ID: 31268127
[TBL] [Abstract][Full Text] [Related]
24. NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States.
Prasad ML; Vyas M; Horne MJ; Virk RK; Morotti R; Liu Z; Tallini G; Nikiforova MN; Christison-Lagay ER; Udelsman R; Dinauer CA; Nikiforov YE
Cancer; 2016 Apr; 122(7):1097-107. PubMed ID: 26784937
[TBL] [Abstract][Full Text] [Related]
25. A Comparison of Morphologic and Molecular Features of BRAF, ALK, and NTRK1 Fusion Spitzoid Neoplasms.
Amin SM; Haugh AM; Lee CY; Zhang B; Bubley JA; Merkel EA; Verzì AE; Gerami P
Am J Surg Pathol; 2017 Apr; 41(4):491-498. PubMed ID: 27776007
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological features and immunohistochemical utility of NTRK-, ALK-, and ROS1-rearranged papillary thyroid carcinomas and anaplastic thyroid carcinomas.
Nozaki Y; Yamamoto H; Iwasaki T; Sato M; Jiromaru R; Hongo T; Yasumatsu R; Oda Y
Hum Pathol; 2020 Dec; 106():82-92. PubMed ID: 32980422
[TBL] [Abstract][Full Text] [Related]
27. Oncogenic TRK fusions are amenable to inhibition in hematologic malignancies.
Taylor J; Pavlick D; Yoshimi A; Marcelus C; Chung SS; Hechtman JF; Benayed R; Cocco E; Durham BH; Bitner L; Inoue D; Chung YR; Mullaney K; Watts JM; Diamond EL; Albacker LA; Mughal TI; Ebata K; Tuch BB; Ku N; Scaltriti M; Roshal M; Arcila M; Ali S; Hyman DM; Park JH; Abdel-Wahab O
J Clin Invest; 2018 Aug; 128(9):3819-3825. PubMed ID: 29920189
[TBL] [Abstract][Full Text] [Related]
28. Identification of NTRK fusions in pediatric mesenchymal tumors.
Pavlick D; Schrock AB; Malicki D; Stephens PJ; Kuo DJ; Ahn H; Turpin B; Allen JM; Rosenzweig M; Badizadegan K; Ross JS; Miller VA; Wong V; Ali SM
Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28097808
[TBL] [Abstract][Full Text] [Related]
29. Case report:
Sheng SJ; Li JM; Fan QH; Liu Y; Chen SY; Zhao M; Gong QX
Front Oncol; 2022; 12():1007296. PubMed ID: 36387173
[No Abstract] [Full Text] [Related]
30. Clinicopathological findings of pediatric NTRK fusion mesenchymal tumors.
Kang J; Park JW; Won JK; Bae JM; Koh J; Yim J; Yun H; Kim SK; Choi JY; Kang HJ; Kim WS; Shin JH; Park SH
Diagn Pathol; 2020 Sep; 15(1):114. PubMed ID: 32957984
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of pan-TRK immunohistochemistry in infantile fibrosarcoma, lipofibromatosis-like neural tumour and histological mimics.
Hung YP; Fletcher CDM; Hornick JL
Histopathology; 2018 Oct; 73(4):634-644. PubMed ID: 29863809
[TBL] [Abstract][Full Text] [Related]
32. Recurrent RET gene fusions in paediatric spindle mesenchymal neoplasms.
Davis JL; Vargas SO; Rudzinski ER; López Marti JM; Janeway K; Forrest S; Winsnes K; Pinto N; Yang SE; VanSandt M; Boyd TK; Corless CL; Liu YJ; Surrey LF; Harris MH; Church A; Al-Ibraheemi A
Histopathology; 2020 Jun; 76(7):1032-1041. PubMed ID: 31994201
[TBL] [Abstract][Full Text] [Related]
33. Identifying patients with NTRK fusion cancer.
Solomon JP; Benayed R; Hechtman JF; Ladanyi M
Ann Oncol; 2019 Nov; 30(Suppl_8):viii16-viii22. PubMed ID: 31738428
[TBL] [Abstract][Full Text] [Related]
34. NTRK-rearranged Cervical Sarcoma: Expanding the Clinicopathologic Spectrum.
Hodgson A; Pun C; Djordjevic B; Turashvili G
Int J Gynecol Pathol; 2021 Jan; 40(1):73-77. PubMed ID: 32044823
[TBL] [Abstract][Full Text] [Related]
35. NTRK Gene Fusion Detection in Atypical Spitz Tumors.
Cappellesso R; Nozzoli F; Zito Marino F; Simi S; Castiglione F; De Giorgi V; Cota C; Senetta R; Scognamiglio G; Anniciello AM; Cesinaro AM; Mandalà M; Gianatti A; Valente MG; Valeri B; Sementa AR; Ricci C; Corti B; Roviello G; Dei Tos AP; Franco R; Massi D
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830218
[TBL] [Abstract][Full Text] [Related]
36. Pan-Trk Immunohistochemistry Identifies NTRK Rearrangements in Pediatric Mesenchymal Tumors.
Rudzinski ER; Lockwood CM; Stohr BA; Vargas SO; Sheridan R; Black JO; Rajaram V; Laetsch TW; Davis JL
Am J Surg Pathol; 2018 Jul; 42(7):927-935. PubMed ID: 29683818
[TBL] [Abstract][Full Text] [Related]
37. ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer.
Pietrantonio F; Di Nicolantonio F; Schrock AB; Lee J; Tejpar S; Sartore-Bianchi A; Hechtman JF; Christiansen J; Novara L; Tebbutt N; Fucà G; Antoniotti C; Kim ST; Murphy D; Berenato R; Morano F; Sun J; Min B; Stephens PJ; Chen M; Lazzari L; Miller VA; Shoemaker R; Amatu A; Milione M; Ross JS; Siena S; Bardelli A; Ali SM; Falcone A; de Braud F; Cremolini C
J Natl Cancer Inst; 2017 Dec; 109(12):. PubMed ID: 29370427
[TBL] [Abstract][Full Text] [Related]
38. Primary and Metastatic Melanoma With NTRK Fusions.
Lezcano C; Shoushtari AN; Ariyan C; Hollmann TJ; Busam KJ
Am J Surg Pathol; 2018 Aug; 42(8):1052-1058. PubMed ID: 29683819
[TBL] [Abstract][Full Text] [Related]
39. NTRK-rearranged spindle cell neoplasms: a clinicopathological and molecular study of 13 cases with peculiar characteristics at one of the largest institutions in China.
Yin L; Shi C; He X; Qiu Y; Chen H; Chen M; Zhang Z; Chen Y; Zhou Y; Zhang H
Pathology; 2023 Apr; 55(3):362-374. PubMed ID: 36641377
[TBL] [Abstract][Full Text] [Related]
40. ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours.
Yamamoto H; Yoshida A; Taguchi K; Kohashi K; Hatanaka Y; Yamashita A; Mori D; Oda Y
Histopathology; 2016 Jul; 69(1):72-83. PubMed ID: 26647767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
